Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06477146Phase 2Recruiting
A Phase 2 trial of silybum marianum extract in non-alcoholic fatty liver disease (NAFLD), sponsored by University Hospitals Cleveland Medical Center. Started Dec 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06477146.